Legal Representation
Attorney
John Mueller
USPTO Deadlines
Application History
14 events| Date | Code | Type | Description |
|---|---|---|---|
| Mar 5, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Mar 5, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Mar 5, 2025 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Mar 5, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Mar 5, 2025 | ECDR | I | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Dec 15, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Nov 20, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Nov 20, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Nov 20, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Aug 21, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Aug 21, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Aug 21, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Aug 21, 2024 | DOCK | D | ASSIGNED TO EXAMINER |
| Jun 4, 2024 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 041
Medical education and training services, namely, conducting classes and workshops education and training to support patients undergoing medical therapy and treatment in the fields of health, wellness, healthcare, pharmaceuticals, pharmaceutical access, drug safety and drug compatibility in relation to as a therapy and treatment of individuals, adherence to pharmaceutical protocols, and the diagnostic, prophylactic and therapeutic properties of pharmaceuticals patient support programs.
Class 044
Providing patient support programs offering medical information to patients undergoing medical therapy and treatment for the purpose of evaluating therapeutic treatment options in the nature of providing a website providing ; patient support program providing disease awareness and disease management information and materials, in the nature of providing a website featuring medical information to improve understanding by patients and caregivers about pharmaceutical information; and patient support program in the nature of health counselling relating to the treatment of respiratory disease; providing medical information.
Classification
International Classes
041
044